105 related articles for article (PubMed ID: 9827363)
1. Increased serum concentrations of secretory leukoprotease inhibitor in patients with primary Sjögren's syndrome.
Maruyama M; Sugiyama E; Hori T; Murayama R; Nakazaki S; Yamashita N; Kobayashi M
In Vivo; 1998; 12(5):535-8. PubMed ID: 9827363
[TBL] [Abstract][Full Text] [Related]
2. Secretory leukocyte protease inhibitor and its potential interactions with elastase and cathepsin B in gingival crevicular fluid and saliva from patients with chronic periodontitis.
Cox SW; Rodriguez-Gonzalez EM; Booth V; Eley BM
J Periodontal Res; 2006 Oct; 41(5):477-85. PubMed ID: 16953825
[TBL] [Abstract][Full Text] [Related]
3. Salivary and serum interleukin 6 in primary Sjögren's syndrome.
Grisius MM; Bermudez DK; Fox PC
J Rheumatol; 1997 Jun; 24(6):1089-91. PubMed ID: 9195514
[TBL] [Abstract][Full Text] [Related]
4. [The clinical study on secretory leukoprotease inhibitor (SLPI) in sera of patients with various pulmonary diseases].
Sugimoto H; Hashimoto N; Ameshima S; Gejyo F; Ishizaki T; Miyabo S
Rinsho Byori; 1995 Dec; 43(12):1267-72. PubMed ID: 8569039
[TBL] [Abstract][Full Text] [Related]
5. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS
J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
[TBL] [Abstract][Full Text] [Related]
6. Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjögren's syndrome.
Laine M; Porola P; Udby L; Kjeldsen L; Cowland JB; Borregaard N; Hietanen J; Ståhle M; Pihakari A; Konttinen YT
Arthritis Rheum; 2007 Aug; 56(8):2575-84. PubMed ID: 17665393
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of hyperprolactinemia in patients with primary Sjögren's syndrome.
Haga HJ; Rygh T
J Rheumatol; 1999 Jun; 26(6):1291-5. PubMed ID: 10381045
[TBL] [Abstract][Full Text] [Related]
8. Salivary secretory leukocyte protease inhibitor increases in HIV infection.
Lin AL; Johnson DA; Stephan KT; Yeh CK
J Oral Pathol Med; 2004 Aug; 33(7):410-6. PubMed ID: 15250833
[TBL] [Abstract][Full Text] [Related]
9. Serum secretory leukoprotease inhibitor levels in chronic bronchitis and Sjögren's syndrome.
Andoh Y; Shimura S; Saitoh H; Sasaki T; Mitsuhashi H; Shirato K
Tohoku J Exp Med; 1997 Aug; 182(4):319-25. PubMed ID: 9352624
[TBL] [Abstract][Full Text] [Related]
10. Kininogen-kallikrein-kinin system in plasma and saliva of patients with Sjögren's syndrome.
Hernández CC; Donadi EA; Reis ML
J Rheumatol; 1998 Dec; 25(12):2381-4. PubMed ID: 9858433
[TBL] [Abstract][Full Text] [Related]
11. Serum amyloid A and C-reactive protein concentrations are differently associated with markers of autoimmunity in patients with primary Sjögren's syndrome.
Pertovaara M; Jylhävä J; Uusitalo H; Pukander J; Helin H; Hurme M
J Rheumatol; 2009 Nov; 36(11):2487-90. PubMed ID: 19833744
[TBL] [Abstract][Full Text] [Related]
12. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development.
Manoussakis MN; Boiu S; Korkolopoulou P; Kapsogeorgou EK; Kavantzas N; Ziakas P; Patsouris E; Moutsopoulos HM
Arthritis Rheum; 2007 Dec; 56(12):3977-88. PubMed ID: 18050195
[TBL] [Abstract][Full Text] [Related]
13. Use of serum secretory leukocyte protease inhibitor levels in patients to improve specificity of ovarian cancer diagnosis.
Tsukishiro S; Suzumori N; Nishikawa H; Arakawa A; Suzumori K
Gynecol Oncol; 2005 Feb; 96(2):516-9. PubMed ID: 15661245
[TBL] [Abstract][Full Text] [Related]
14. Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome.
van Woerkom JM; Kruize AA; Wenting-van Wijk MJ; Knol E; Bihari IC; Jacobs JW; Bijlsma JW; Lafeber FP; van Roon JA
Ann Rheum Dis; 2005 Oct; 64(10):1474-9. PubMed ID: 15817659
[TBL] [Abstract][Full Text] [Related]
15. Secreted leukocyte protease inhibitor is present in aqueous humours from cataracts and other eye pathologies.
Janciauskiene S; Brandt L; Wallmark A; Westin U; Krakau T
Exp Eye Res; 2006 Mar; 82(3):505-11. PubMed ID: 16202405
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of soluble CD44 in primary Sjögren's syndrome.
Levesque MC; Mackin DA; Fleming JA; St Clair EW
J Rheumatol; 2000 Jun; 27(6):1444-9. PubMed ID: 10852268
[TBL] [Abstract][Full Text] [Related]
17. Increased levels of interleukin-10 in saliva of Sjögren's syndrome patients. Correlation with disease activity.
Bertorello R; Cordone MP; Contini P; Rossi P; Indiveri F; Puppo F; Cordone G
Clin Exp Med; 2004 Dec; 4(3):148-51. PubMed ID: 15599664
[TBL] [Abstract][Full Text] [Related]
18. Serum secretory leukoprotease inhibitor levels to diagnose pneumonia in the elderly.
Kida K; Mizuuchi T; Takeyama K; Hiratsuka T; Jinno S; Hosoda K; Imaizumi A; Suzuki Y
Am Rev Respir Dis; 1992 Dec; 146(6):1426-9. PubMed ID: 1360778
[TBL] [Abstract][Full Text] [Related]
19. Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome.
Gottenberg JE; Busson M; Cohen-Solal J; Lavie F; Abbed K; Kimberly RP; Sibilia J; Mariette X
Ann Rheum Dis; 2005 Jul; 64(7):1050-5. PubMed ID: 15640273
[TBL] [Abstract][Full Text] [Related]
20. [Effects of secretory leukocyte protease inhibitor on the production of some cytokines and nitric oxide by murine peritoneal macrophages in response to lipopolysaccharide stimulation and M. avium complex infection].
Sano C; Shimizu T; Sato K; Ogasawara K; Tomioka H
Kekkaku; 1999 Jul; 74(7):563-70. PubMed ID: 10481411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]